Figure 5

LEIGC knockdown enhanced the tumorigenic potential of gastric carcinoma cells in vivo. (A). Exposure of tumors inoculated with LEIGC-shRNA vector cells (shRNA) and scrambled shRNA vector (NC1) when mice were sacrificed. (A). Representative image of xenograft tumors in NOD/SCID mice subcutaneously injected with MGC-803 cells; 1, 2, 3, and 4 indicate the different mice. (B). Comparison of xenograft formation in vivo. Tumor volumes were measured each week. Error bars represent means ± SEM, *P < 0.05.